Opus Genetics, Inc. (IRD) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts IRD Hot Sheet
Join SI Premium – FREE
Opus Genetics, Inc. (NASDAQ: IRD) reported Q2 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Aktis Oncology (AKTS) at Outperform
- BofA Securities Downgrades Patria Investments (PAX) to Underperform
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
